These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins. Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743 [TBL] [Abstract][Full Text] [Related]
3. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. Matos MJ; Viña D; Janeiro P; Borges F; Santana L; Uriarte E Bioorg Med Chem Lett; 2010 Sep; 20(17):5157-60. PubMed ID: 20659799 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387 [TBL] [Abstract][Full Text] [Related]
5. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives. Reniers J; Meinguet C; Moineaux L; Masereel B; Vincent SP; Frederick R; Wouters J Eur J Med Chem; 2011 Dec; 46(12):6104-11. PubMed ID: 22018876 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors. Reniers J; Robert S; Frederick R; Masereel B; Vincent S; Wouters J Bioorg Med Chem; 2011 Jan; 19(1):134-44. PubMed ID: 21183355 [TBL] [Abstract][Full Text] [Related]
8. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches. Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
11. 8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase. Strydom B; Bergh JJ; Petzer JP Eur J Med Chem; 2011 Aug; 46(8):3474-85. PubMed ID: 21621312 [TBL] [Abstract][Full Text] [Related]
12. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling. Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832 [TBL] [Abstract][Full Text] [Related]
13. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies. Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones. Tripathi RK; Goshain O; Ayyannan SR ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and inhibitory effect of piperine derivates on monoamine oxidase. Mu LH; Wang B; Ren HY; Liu P; Guo DH; Wang FM; Bai L; Guo YS Bioorg Med Chem Lett; 2012 May; 22(9):3343-8. PubMed ID: 22475561 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines. Secci D; Bolasco A; Carradori S; D'Ascenzio M; Nescatelli R; Yáñez M Eur J Med Chem; 2012 Dec; 58():405-17. PubMed ID: 23153812 [TBL] [Abstract][Full Text] [Related]